Does the addition of trastuzumab (HER-2/neu inhibition) to fulvestrant therapy improve response in women with advanced breast cancer.
Phase of Trial: Phase IV
Latest Information Update: 06 May 2015
At a glance
- Drugs Fulvestrant (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 06 May 2015 New trial record